Future research may also explore the effects of PD-1/PD-L1 blockade-based therapies in patients with high PD-1/PD-L1 expression, as well as incorporate the Combined Positive Score (CPS) method to assess PD-L1 expression more comprehensively by including both tumor cells and immune cells in the tumor microenvironment. Here, CD274 is linked to neoplasm.